Literature DB >> 28054107

[Evidence-based supportive measures to secure pancreatic anastomoses].

O Belyaev1, W Uhl2.   

Abstract

BACKGROUND: Pancreatic anastomosis is the Achilles heel of pancreatic surgery. Despite substantial progress in surgical techniques the rate of postoperative pancreatic fistulas remains very high. For this reason various supportive measures to secure pancreatic anastomoses are of continuing interest.
OBJECTIVE: This review presents the newest evidence-based data on supportive measures designed to secure a pancreatic anastomosis.
MATERIAL AND METHODS: The most recent meta-analyses, randomized controlled trials and the largest retrospective studies on the role of pancreatic duct stenting, double loop reconstruction, autologous patches and drainage in pancreaticoduodenectomy were taken into account. The value of somatostatin analogues, perioperative nutrition and fluid management is critically discussed.
RESULTS: The existing body of evidence on supportive measures is insufficient and remains controversial. The use of somatostatin analogues, drainages and restrictive perioperative fluid management has proven effective. In contrast, routine stenting of the pancreatic duct cannot be recommended. Other approaches, such as double loop reconstruction and use of autologous patches lack sufficient evidence.
CONCLUSION: Meticulous surgical technique and surgeon experience remain the cornerstones of performing a safe pancreatic anastomosis; however, some additional supportive measures seem to have significant potential and should be further investigated in large and well-designed prospective clinical trials.

Entities:  

Keywords:  Ligamentum teres; Pancreatic fistula; Pancreaticoduodenectomy; Somatostatin analogue; Stent

Mesh:

Substances:

Year:  2017        PMID: 28054107     DOI: 10.1007/s00104-016-0336-5

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  38 in total

1.  Early Drain Removal--The Middle Ground Between the Drain Versus No Drain Debate in Patients Undergoing Pancreaticoduodenectomy: A Prospective Validation Study.

Authors:  Zhi Ven Fong; Camilo Correa-Gallego; Cristina R Ferrone; Gregory R Veillette; Andrew L Warshaw; Keith D Lillemoe; Carlos Fernández-del Castillo
Journal:  Ann Surg       Date:  2015-08       Impact factor: 12.969

Review 2.  Prophylactic abdominal drainage for pancreatic surgery.

Authors:  Su Peng; Yao Cheng; Chen Yang; Jiong Lu; Sijia Wu; Rongxing Zhou; Nansheng Cheng
Journal:  Cochrane Database Syst Rev       Date:  2015-08-21

3.  Prophylactic octreotide for pancreatoduodenectomy: more harm than good?

Authors:  Matthew T McMillan; John D Christein; Mark P Callery; Stephen W Behrman; Jeffrey A Drebin; Tara S Kent; Benjamin C Miller; Russell S Lewis; Charles M Vollmer
Journal:  HPB (Oxford)       Date:  2014-07-10       Impact factor: 3.647

4.  A prospective, randomized trial of Roux-en-Y reconstruction with isolated pancreatic drainage versus conventional loop reconstruction after pancreaticoduodenectomy.

Authors:  Shan Ke; Xue-mei Ding; Jun Gao; Ai-min Zhao; Gao-yue Deng; Rui-liang Ma; Zong-hai Xin; Chun-min Ning; Wen-bing Sun
Journal:  Surgery       Date:  2013-04-16       Impact factor: 3.982

5.  Early Enteral Versus Total Parenteral Nutrition in Patients Undergoing Pancreaticoduodenectomy: A Randomized Multicenter Controlled Trial (Nutri-DPC).

Authors:  Julie Perinel; Christophe Mariette; Bertrand Dousset; Igor Sielezneff; Alain Gainant; Jean-Yves Mabrut; Sylvie Bin-Dorel; Michel El Bechwaty; Dominique Delaunay; Lorraine Bernard; Alain Sauvanet; Marc Pocard; Emmanuel Buc; Mustapha Adham
Journal:  Ann Surg       Date:  2016-11       Impact factor: 12.969

Review 6.  Somatostatin analogues for pancreatic surgery.

Authors:  Kurinchi Selvan Gurusamy; Rahul Koti; Giuseppe Fusai; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2013-04-30

7.  Prophylactic pasireotide administration following pancreatic resection reduces cost while improving outcomes.

Authors:  Daniel E Abbott; Jeffrey M Sutton; Peter L Jernigan; Alex Chang; Patrick Frye; Shimul A Shah; Daniel P Schauer; Mark H Eckman; Syed A Ahmad; Jeffrey J Sussman
Journal:  J Surg Oncol       Date:  2016-04-04       Impact factor: 3.454

8.  The effect of intraoperative fluid volume administration on pancreatic fistulas after pancreaticoduodenectomy.

Authors:  Sizhen Wang; Xinbo Wang; Hongshan Dai; Jianming Han; Ning Li; Jieshou Li
Journal:  J Invest Surg       Date:  2014-04       Impact factor: 2.533

9.  No Need for Routine Drainage After Pancreatic Head Resection: The Dual-Center, Randomized, Controlled PANDRA Trial (ISRCTN04937707).

Authors:  Helmut Witzigmann; Markus K Diener; Stefan Kienkötter; Inga Rossion; Thomas Bruckner; Olaf Pridöhl; Olga Radulova-Mauersberger; Heike Lauer; Phillip Knebel; Alexis Ulrich; Oliver Strobel; Thilo Hackert; Markus W Büchler
Journal:  Ann Surg       Date:  2016-09       Impact factor: 12.969

10.  A randomized prospective multicenter trial of pancreaticoduodenectomy with and without routine intraperitoneal drainage.

Authors:  George Van Buren; Mark Bloomston; Steven J Hughes; Jordan Winter; Stephen W Behrman; Nicholas J Zyromski; Charles Vollmer; Vic Velanovich; Taylor Riall; Peter Muscarella; Jose Trevino; Attila Nakeeb; C Max Schmidt; Kevin Behrns; E Christopher Ellison; Omar Barakat; Kyle A Perry; Jeffrey Drebin; Michael House; Sherif Abdel-Misih; Eric J Silberfein; Steven Goldin; Kimberly Brown; Somala Mohammed; Sally E Hodges; Amy McElhany; Mehdi Issazadeh; Eunji Jo; Qianxing Mo; William E Fisher
Journal:  Ann Surg       Date:  2014-04       Impact factor: 12.969

View more
  1 in total

1.  Is primary total pancreatectomy in patients with high-risk pancreatic remnant justified and preferable to pancreaticoduodenectomy? -a matched-pairs analysis of 200 patients.

Authors:  Andreas Minh Luu; Bella Olchanetski; Torsten Herzog; Andrea Tannapfel; Waldemar Uhl; Orlin Belyaev
Journal:  Gland Surg       Date:  2021-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.